103 related articles for article (PubMed ID: 22810753)
1. Thalidomide therapy for aggressive histiocytic lesions in the pediatric population.
Bailey KM; Castle VP; Hummel JM; Piert M; Moyer J; McAllister-Lucas LM
J Pediatr Hematol Oncol; 2012 Aug; 34(6):480-3. PubMed ID: 22810753
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic features of histiocytic lesions following ALL, with a review of the literature.
Castro EC; Blazquez C; Boyd J; Correa H; de Chadarevian JP; Felgar RE; Graf N; Levy N; Lowe EJ; Manning JT; Proytcheva MA; Senger C; Shayan K; Sterba J; Werner A; Surti U; Jaffe R
Pediatr Dev Pathol; 2010; 13(3):225-37. PubMed ID: 19642834
[TBL] [Abstract][Full Text] [Related]
3. Eruptive juvenile xanthogranuloma associated with relapsing acute lymphoblastic leukemia.
Aparicio G; Mollet J; Bartralot R; Bodet D; Heras C; Bassas P; Virós A; García-Patos V
Pediatr Dermatol; 2008; 25(4):487-8. PubMed ID: 18789100
[TBL] [Abstract][Full Text] [Related]
4. Recovery of vision after adjuvant thalidomide in a child with tuberculous meningitis and acute lymphoblastic leukemia.
Stefan DC; Andronikou S; Freeman N; Schoeman J
J Child Neurol; 2009 Feb; 24(2):166-9. PubMed ID: 19182153
[TBL] [Abstract][Full Text] [Related]
5. Mediastinal Germ Cell Tumor-associated Histiocytic Proliferations Treated With Thalidomide Plus Chemotherapy Followed by Alemtuzumab-containing Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation: A Case Report.
Fang LH; Shih LS; Lee PI; Chen WT; Chen RL
Medicine (Baltimore); 2016 Jan; 95(2):e2515. PubMed ID: 26765473
[TBL] [Abstract][Full Text] [Related]
6. Autologous hematopoietic stem-cell transplantation in combination with thalidomide as treatment for histiocytic sarcoma: a case report and review of the literature.
Gergis U; Dax H; Ritchie E; Marcus R; Wissa U; Orazi A
J Clin Oncol; 2011 Apr; 29(10):e251-3. PubMed ID: 21220616
[No Abstract] [Full Text] [Related]
7. Haemophagocytic syndrome complicating acute lymphoblastic leukaemia.
Stark R; Manoharan A
Postgrad Med J; 1989 Apr; 65(762):249-52. PubMed ID: 2687829
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of refractory metastatic histiocytic sarcoma with alemtuzumab.
Shukla N; Kobos R; Renaud T; Teruya-Feldstein J; Price A; McAllister-Lucas L; Steinherz P
Cancer; 2012 Aug; 118(15):3719-24. PubMed ID: 22170006
[TBL] [Abstract][Full Text] [Related]
9. Descriptive Analysis of Histiocytic and Dendritic Cell Neoplasms: A Single-Institution Experience.
Kim HM; Yang WI; Lyu CJ; Hahn SM; Yoon SO
Yonsei Med J; 2020 Sep; 61(9):774-779. PubMed ID: 32882761
[TBL] [Abstract][Full Text] [Related]
10. [Eruptive xanthogranulomatosis in a trisomy 21 patient with acute lymphoblastic leukemia].
Sarthou-Bruere S; Milpied-Homsi B; Mahe B; Cassagnau E; Stalder JF
Ann Dermatol Venereol; 2000 Jan; 127(1):80-2. PubMed ID: 10717571
[TBL] [Abstract][Full Text] [Related]
11. Pediatric histiocytic sarcoma clonally related to precursor B-cell acute lymphoblastic leukemia with homozygous deletion of CDKN2A encoding p16INK4A.
Kumar R; Khan SP; Joshi DD; Shaw GR; Ketterling RP; Feldman AL
Pediatr Blood Cancer; 2011 Feb; 56(2):307-10. PubMed ID: 20973102
[TBL] [Abstract][Full Text] [Related]
12. Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant.
Abidi MH; Tove I; Ibrahim RB; Maria D; Peres E
Am J Hematol; 2007 Oct; 82(10):932-3. PubMed ID: 17617785
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of thalidomide in a child with histiocytic sarcoma following allogeneic bone marrow transplantation for T-ALL.
Dalle JH; Leblond P; Decouvelaere A; Yakoub-Agha I; Preudhomme C; Nelken B; Mazingue F
Leukemia; 2003 Oct; 17(10):2056-7. PubMed ID: 14513060
[No Abstract] [Full Text] [Related]
14. Treatment of severe disseminated juvenile systemic xanthogranuloma with multiple lesions in the central nervous system.
Dölken R; Weigel S; Schröder H; Hartwig M; Harms D; Beck JF
J Pediatr Hematol Oncol; 2006 Feb; 28(2):95-7. PubMed ID: 16462582
[TBL] [Abstract][Full Text] [Related]
15. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
[TBL] [Abstract][Full Text] [Related]
16. Unusual presentation of a rare cancer: histiocytic sarcoma in the brain 16 years after treatment for acute lymphoblastic leukemia.
Chalasani S; Hennick MR; Hocking WG; Shaw GR; Lawler B
Clin Med Res; 2013 Feb; 11(1):31-5. PubMed ID: 22997353
[TBL] [Abstract][Full Text] [Related]
17. Xanthogranulomas associated with hematologic malignancy in adulthood.
Shoo BA; Shinkai K; McCalmont TH; Fox LP
J Am Acad Dermatol; 2008 Sep; 59(3):488-93. PubMed ID: 18538449
[TBL] [Abstract][Full Text] [Related]
18. Treatment of juvenile xanthogranuloma.
Stover DG; Alapati S; Regueira O; Turner C; Whitlock JA
Pediatr Blood Cancer; 2008 Jul; 51(1):130-3. PubMed ID: 18338395
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report.
Sebastiani M; Puccini R; Manfredi A; Manni E; Colaci M; Mattei P; Barachini P; Ferri C
Ther Apher Dial; 2009 Jun; 13(3):225-8. PubMed ID: 19527470
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide for the treatment of hydroa vacciniforme-like lymphoma: report of four pediatric cases from Peru.
Beltrán BE; Maza I; Moisés-Alfaro CB; Vasquez L; Quiñones P; Morales D; Sánchez G; Paredes G; Oscanoa M; Gerónimo J; Miranda RN; Castillo JJ
Am J Hematol; 2014 Dec; 89(12):1160-1. PubMed ID: 25196949
[No Abstract] [Full Text] [Related]
[Next] [New Search]
